Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer.

Date publication

octobre 2022

Journal

JAMA network open

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BOUVIER Anne-Marie , Dr JOOSTE Valérie

Tous les auteurs :
Reboux N, Jooste V, Goungounga J, Robaszkiewicz M, Nousbaum JB, Bouvier AM

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36239935

Résumé

Although treatment and prognosis of synchronous liver metastases from colorectal cancer are relatively well known, a comparative description of the incidence, epidemiological features, and outcomes of synchronous and metachronous liver metastases is lacking. The difference in prognosis between patients with synchronous and metachronous liver metastases is controversial.

Référence

JAMA Netw Open. 2022 10 3;5(10):e2236666